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A phage repertoire was constructed using antibody genes from the bone marrow and the spleen of a rabbit immunized with Cry1Ab toxin. Biopanning 
against either the Cry1Ab toxin or a domain II loop 3 synthetic peptide resulted in the identification of monoclonal antibodies in scFv format. They 
inhibited binding and toxicity of Cry1Ab toxin against Manduca sexta. Toxin overlay assays, using the scFv antibodies as competitors, revealed that the 
anti-loop 3 molecule competed with Cry1Ab toxin binding to the cadherin receptor (Bt-R1) of M. sexta, while anti-domain III antibodies interfered with 
the binding of Cry1Ab toxin to the aminopeptidase N (APN) receptor of this insect.
Introduction
Insecticidal  Cry1  proteins  from  Bacillus  thuringiensis 
(Bt)  are  used  in  biopesticides  and  transgenic  crops 
(2). In susceptible insects, proteinases in the alkaline 
midgut activate the Cry protein to a toxin that binds 
with  high  affinity  to  receptors  of  the  brush  border 
epithelium  membrane.  In  the  case  of  the  cadherin 
receptor Bt-R1, toxin binding initiates a conformational 
change that results in the assembly of a pre-pore toxin 
oligomer  (5). Aminopeptidases  also  bind  Cry1  toxins 
and  facilitate  toxin-induced  pore  formation  (8).  An 
emerging model suggests that after binding cadherins, 
toxins bind aminopeptidases and insert into membrane 
microdomains called lipid rafts (3). Domain II determines 
specificity,  because  it  represents  the  most  divergent 
part  of  the  toxin  sequence,  and  exchanging  domain 
II, or domains II and III, between closely related toxins 
resulted in active hybrids showing altered specificity (4,6). 
Materials and methods
Phage  display  libraries  construction.  Total  RNA 
from spleen tissue and bone marrow of an immunized 
rabbit was used for first strand cDNA synthesis. Heavy- 
and  light-chain  genes  were  amplified  separately  and 
recombined by three subsequent PCR, essentially as 
described (7). In order to construct the scFv libraries, 
scFv DNA and phagemid vector were digested with SfiI 
and NotI (New England BioLabs, Beverly, MA, USA), 
and ligated. The purified DNA was electroporated into 
TG1  electrocompetent  cells.  Each  library  was  grown 
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on  large  TYE  AMP  GLU  agar  plates.  For  panning, 
phage preparations were purified and concentrated by 
polyethylene glycol precipitation.
Selection and characterization of phage-displayed 
antibodies.  Panning  was  carried  out  essentially  as 
described previously (7) using 50 µg of Cry1Ab. 1011 
phage were used in each round of selection. Binders 
were eluted with 1 ml of triethylamine (100 mM) and 
the  eluant  was  neutralized  and  mixed  with  8.5  ml 
of  exponentially  growing  TG-1  cells. An  aliquot  was 
removed for titration, measured as colony forming units 
on agar plates. Infected bacteria were plated on TYE 
AMP  GLU  agar  plates  and  bacteria  were  harvested 
after ON growth at 37°C. Phages were rescued for the 
next selection cycle.
Insect bioassay. Bioassays were performed on M. sexta 
neonate larvae by the surface contamination method. 
The toxin solution was preincubated with selected phages 
for 1 h then poured on the diet surface and allowed to 
dry. Neonate M. sexta larvae were placed on the dried 
surface and mortality was monitored after 7 days.
Results
Phage  antibody  library  construction  and  charac-
terization. After cDNA synthesis by reverse transcription 
from spleen and bone marrow RNA samples, the VH and 
VL region gene repertoires were amplified separately by 
PCR. In the second PCR reaction, a DNA linker coding 
a (Gly4Ser)3 peptide linker sequence was added using 13
modified 3´-heavy and 5´-light chains primers. Finally, 
a  third  PCR  reaction  was  performed  to  fuse  heavy 
and light chain genes by overlapping extension. PCR 
products  from  the  third  PCR  reaction  were  digested 
with SfiI and NotI, and cloned into phagemid vectors 
pSyn2 or pCANTAB that allow the display of the cloned 
fragment on M13 phage. After transformation, libraries 
sizes of 2.0 x 106 members were obtained.
To examine the integrity of the libraries, 20 clones of 
each library were picked at random and 95% of the 
clones  were  found  by  PCR  to  contain  scFv  genes 
having the expected size. To determine the diversity 
of the gene content of the libraries, cloned scFv genes 
were amplified from the same colonies and digested 
with  the  AluI  restriction  enzyme.  PCR  fingerprinting 
analysis of bone marrow and spleen libraries showed 
that  the  libraries  were  diverse  since  all  restriction 
patterns analyzed were different.
Identification  of  anti-loop  3  and  anti-domain  III 
phage  antibodies.  For  the  identification  of  anti-loop 
3 scFv antibodies, the libraries were panned against 
a  synthetic  biotinylated  peptide  with  a  sequence 
corresponding  to  the  Cry1Ab  loop  3.  The  panning 
procedure consisted in two selection rounds against the 
whole Cry1Ab toxin and a third panning round against 
the biotinylated loop 3 synthetic peptide. Fingerprinting 
analysis revealed five different restriction patterns. In 
ELISA, all clones bound to Cry1Ab and Cry1Ac, but did 
not bind to Cry1Aa which has a different loop 3 amino 
acid sequence, suggesting that these scFv bind loop 3 
of Cry1Ab. After two rounds of panning against Cry1Ab, 
a final panning round was conducted against Cry1Ab 
in the presence of soluble Cry1Ac to ensure binding to 
Cry1Ab toxin of phages that do not recognize Cry1Ac. 
Fifty colonies from the fourth round were amplified by 
PCR and characterized by fingerprinting analysis. Five 
different  restriction  patterns  were  identified. Analysis 
of  binding  to  the  three  Cry1A  proteins  revealed  that 
three scFv phages bound to Cry1Ab, but not to Cry1Ac 
which has a different domain III sequence, suggesting 
that these scFv antibodies bind Cry1Ab toxin through 
domain III.
Effect of phage antibodies on toxicity of Cry1Ab 
toxin to M. sexta larvae. First instar larvae were fed 
Cry1Ab toxin either alone or Cry1Ab pre-incubated 
with 108 phage preparation of the different monoclonal 
scFv antibodies selected after four rounds of selection. 
None of the phages were toxic to M. sexta larvae. 
All of the anti-loop 3 phages reduced the toxicity 
of Cry1Ab to 30-60% while the two anti-domain III 
phages reduced it to 10-20%.
Discussion
The  striking  dissimilarity  between  domain  II  and 
domain III amino acid sequences of different Cry toxins 
motivated us to investigate the role of these regions 
in insect specificity, toxicity and binding using phage 
display antibodies against these regions. We generated 
immune libraries in the scFv format that could be used 
for efficient selection of high-affinity and specific scFv 
antibodies  against  Cry1Ab  toxin.  We  identified  scFv 
phages that recognized domain II loop 3 or domain III, 
since these regions are likely to be involved in receptor 
interaction (1, 6).
Rabbit  immune  repertoires  from  spleen  or  bone 
marrow yielded a great diversity. Using phage display 
technology, after three or four rounds of panning using 
Cry1Ab toxin, we isolated specific scFv antibodies from 
the pool of the two libraries, that inhibited toxicity. Among 
these, antibody M22 was particularly interesting. M22, 
in  contrast  to  the  other  anti-Cry1Ab  scFv  molecules 
analyzed,  recognized  Cry1Ab  but  did  not  bind  to 
Cry1Ac. Therefore, scFv M22 most likely recognized a 
certain domain III region involved in toxicity, since this 
antibody reduced the toxicity of Cry1Ab toxin. In the 
case of Cry1Ac toxin, domain III is important on APN 
binding (4). We were able also to obtain five specific 
scFv antibodies against loop 3 of domain II. All anti-loop 
3 scFv molecules analyzed recognized Cry1Ab but did 
not bind to Cry1Aa, consistent with the fact that these 
toxins do not share sequence similarity in the loop 3 
region. Our results show the efficacy of our libraries 
for the generation of highly specific reagents against 
specific  regions  of  Cry  toxins  to  study  toxin-receptor 
interaction.  Our  set  of  recombinant  scFv  antibodies 
against Cry1Ab toxin represents the first demonstration 
of the recombinant-antibody approach to the study of 
toxin-receptor  and  structure-function  relations.  With 
these tools it should be possible now to characterize 
more thoroughly the toxin-receptor interactions of Cry 
proteins and to ascertain the role of these interactions 
in the mode of action of these important toxins.14
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